Specimen and Data Collection in South Carolina Medicaid-Enrolled Patients With Type 2 Diabetes (T2D) and Metabolically Healthy Controls

Part of paid clinical trials in Orangeburg, South Carolina.

Sponsor
Guardian Research Network, Inc.
Study ID
NCT07731399
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
40 Years - 70 Years
Healthy Volunteers
Accepted

Interventions

  • Not applicable- observational study — OTHER
    Non-interventional biospecimen and data collection study.

Study Details

The primary purpose of this study is to use multiomic data in combination with clinical assessments, electronic health records, cognitive and mood assessments, wearable technologies and lifestyle/behavioral data to identify data elements or combinations of data elements with strong positive or negative correlation to CKD diagnosis and/or progression in Type 2 Diabetes (T2D) patients. Achieving this aim will allow researchers and physicians to significantly improve the prediction of health trajectories of and formulate novel strategies to potentially prevent, treat or reverse T2D. South Carolina Medicaid-enrolled patients diagnosed with T2D and a smaller subset of non-T2D SC Medicaid patients may participate in this study. Participants who complete required procedures will be compensated for their time and transportation, may keep their study-provided Fitbit device to help maintain their healthcare improvement journey, and will have a personal Certified Diabetes Educator to consult and assist with managing their diabetes diagnosis.

Key Dates

First listed
Jul 28, 2026
Start date
Jul 31, 2026
Status verified
Jul 2026
Primary completion
Aug 31, 2029
Completion
Oct 31, 2029

Study Design

Enrollment
1,200 participants (estimated)

Arms

  • Arm: Type 2 Diabetes
    SC Medicaid-enrolled Type 2 Diabetes Patients
  • Arm: Healthy Controls
    SC Medicaid-enrolled non-T2D Patients

Primary Outcome Measure

Identify data elements or combinations of data elements with strong positive or negative correlation to Chronic Kidney Disease diagnosis and/or progression in Type 2 Diabetes patients [ Time Frame: Up to 24 months after enrollment ]

Locations (2)

FacilityCityStateZIPSite coordinators
Clemson Health Clinic at OrangeburgOrangeburgSouth Carolina29118
Katie Poplin
[email protected]
864-656-4503
Jeremy Shields
[email protected]
864-656-4503
Peter Carek, MD (PRINCIPAL_INVESTIGATOR)
Clemson Health Clinic at WalhallaWalhallaSouth Carolina29691
Katie Poplin
[email protected]
864-656-4503
Jeremy Shields
[email protected]
864-656-4503
Peter Carek, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Orangeburg, SC

Nationwide
Type 2 diabetes trialsEndocrinology trialsMetabolic health trialsWeight loss trials
By condition
Type 2 diabetes
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
Clemson Health Clinic at Orangeburg· Orangeburg, SCClemson Health Clinic at Walhalla· Walhalla, SC

Related Studies